標題: Titlebook: Best Practices in Processing and Storage for Hematopoietic Cell Transplantation; Joseph Schwartz,Beth H. Shaz Book 2018 The Editor(s) (if [打印本頁] 作者: 矜持 時間: 2025-3-21 18:10
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation影響因子(影響力)
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation影響因子(影響力)學(xué)科排名
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation網(wǎng)絡(luò)公開度
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation被引頻次
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation被引頻次學(xué)科排名
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation年度引用
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation年度引用學(xué)科排名
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation讀者反饋
書目名稱Best Practices in Processing and Storage for Hematopoietic Cell Transplantation讀者反饋學(xué)科排名
作者: Latency 時間: 2025-3-21 22:08 作者: 思考才皺眉 時間: 2025-3-22 03:27 作者: ESO 時間: 2025-3-22 05:05
978-3-319-86517-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: 軌道 時間: 2025-3-22 12:48 作者: neolith 時間: 2025-3-22 16:10 作者: Encoding 時間: 2025-3-22 19:41 作者: mendacity 時間: 2025-3-22 22:11
C. Biran,M. Bordeau,M. P. Legerss. Donor qualification refers to aspects of the donor that may affect safety of the donor, safety of the recipient, and success of the HPC transplantation in the recipient. This definition is synonymous with the term “donor suitability” used by the World Marrow Donor Association (WMDA) and American作者: 天然熱噴泉 時間: 2025-3-23 04:02 作者: 言外之意 時間: 2025-3-23 08:11
Trends and applications of thermogravimetry,poietic cell transplantation is rapidly evolving as is our understanding of cellular immunity. Along with this knowledge has come the ability to engineer hematopoietic progenitor cell (HPC) grafts collected from allogeneic donors in the clinical laboratory. Methods including CD34. enrichment and T-c作者: CYT 時間: 2025-3-23 10:04
Inorganic and Physical Chemistryither refrigerated or room temperatures for approximately 72 h following collection. Cryopreservation enables long-term storage of HPC products and is used extensively for autologous products collected prior to high-dose chemotherapy (HDT) that are intended for use after treatment to rescue hematopo作者: 教唆 時間: 2025-3-23 16:40 作者: Diuretic 時間: 2025-3-23 19:59
,The Metal—Nonmetal Bond in the Solid State,nsplantation. The process commences with the recruitment and selection of a suitable donor and finishes with the CB unit (CB) meeting the requirements of pre-release testing parameters, the quality of the product ultimately confirmed by the outcomes observed posttransplant. CB is a biological produc作者: 是他笨 時間: 2025-3-24 00:19
https://doi.org/10.1007/978-1-4899-2459-9as a source of HPCs, other neonatal cell types, and proteins for biomedical research and new therapies, such as ophthalmological tissue regeneration and platelet lysates for tissue culture. This chapter will review the methods used to prepare a volume-reduced HPC-enriched fraction from the blood col作者: Subjugate 時間: 2025-3-24 03:59
Amphibole group of silicates (Text 2),s, particularly those of ethnic minorities. With the growth of the worldwide CB Inventory, most patients will have several potential HLA-matched CB units (CBU); still, selection of the most appropriate CB graft for transplantation remains a complex decision since there are many considerations relate作者: maintenance 時間: 2025-3-24 07:37 作者: 愛好 時間: 2025-3-24 12:44
Amphibole group of silicates (Text 1),CT) and related allogeneic CD34. cell products are often collected and processed in the same facility as the transplant center. This is not the case, however, for unrelated donor cord blood, peripheral blood, or bone marrow transplantation that are facilitated by registries—such as the National Marr作者: ANN 時間: 2025-3-24 16:52 作者: ETHER 時間: 2025-3-24 22:50 作者: 匯總 時間: 2025-3-25 00:52
https://doi.org/10.1007/978-94-011-2612-0being highly qualified to perform cellular therapy activities and to have a high quality of operations. The federal government has granted deemed status to certain accreditation organizations that have standards and a survey process that meets or exceeds Medicare and Medicaid requirements. Laborator作者: Mawkish 時間: 2025-3-25 07:12 作者: mucous-membrane 時間: 2025-3-25 09:02
Inorganic and Physical Chemistryer for cryopreservation to be an effective tool, when thawed and infused, HPC must be able to regain their ability to proliferate, engraft, and provide the same functional capability prior to cryopreservation. Pre-cryopreservation storage conditions and manipulation procedures, cryoprotectant formul作者: agonist 時間: 2025-3-25 14:41
https://doi.org/10.1007/978-1-4899-2459-9ntly, automated methods for withdrawing the buffy coat have been introduced that allow for aliquots of the cord blood unit (CBU) to be segregated into sealed “segments” of its integral plastic tubing, enabling monitoring the identity, viability, and potency of the CBU, including testing at the time 作者: 杠桿支點 時間: 2025-3-25 18:38
Amphibole group of silicates (Text 2),splantation. Since no selection algorithm “fits all,” transplant centers need to develop their own selection criteria based on their specific studies as well as their results of post-thaw CBU evaluation and outcomes.作者: 小畫像 時間: 2025-3-25 21:12 作者: 多嘴多舌 時間: 2025-3-26 01:02 作者: 恃強凌弱的人 時間: 2025-3-26 07:09 作者: Canyon 時間: 2025-3-26 11:20
Cryopreservation Techniques and Freezing Solutionser for cryopreservation to be an effective tool, when thawed and infused, HPC must be able to regain their ability to proliferate, engraft, and provide the same functional capability prior to cryopreservation. Pre-cryopreservation storage conditions and manipulation procedures, cryoprotectant formul作者: 牙齒 時間: 2025-3-26 14:50 作者: 自戀 時間: 2025-3-26 19:42 作者: Congruous 時間: 2025-3-26 20:56 作者: Emmenagogue 時間: 2025-3-27 02:12 作者: 怎樣才咆哮 時間: 2025-3-27 05:37
Journey of Hematopoietic Cells: Processing to Infusion,used to treat a wide variety of diseases, most commonly leukemias, lymphomas, multiple myeloma, and certain solid tumors. Hematopoietic graft sources include bone marrow, peripheral blood, and cord blood. To maintain a high-quality product to ensure engraftment and optimal patient outcomes, each ste作者: 黃油沒有 時間: 2025-3-27 11:04
Regulations and Accreditation of Processing Laboratories,enters for Medicare and Medicaid Services (CMS) are the main governing bodies that provide federal oversight. State health departments may also have local regulations for processing laboratories. Individuals and institutions involved in cellular therapy processing must be familiar with the requireme作者: CODA 時間: 2025-3-27 15:40 作者: UNT 時間: 2025-3-27 20:22 作者: GRAVE 時間: 2025-3-28 01:12
CD34+ Enrichment and T-Cell Depletionpoietic cell transplantation is rapidly evolving as is our understanding of cellular immunity. Along with this knowledge has come the ability to engineer hematopoietic progenitor cell (HPC) grafts collected from allogeneic donors in the clinical laboratory. Methods including CD34. enrichment and T-c作者: HAVOC 時間: 2025-3-28 05:57
Cryopreservation Techniques and Freezing Solutionsither refrigerated or room temperatures for approximately 72 h following collection. Cryopreservation enables long-term storage of HPC products and is used extensively for autologous products collected prior to high-dose chemotherapy (HDT) that are intended for use after treatment to rescue hematopo作者: filicide 時間: 2025-3-28 08:21 作者: HILAR 時間: 2025-3-28 14:00
Cord Blood Donor Qualificationnsplantation. The process commences with the recruitment and selection of a suitable donor and finishes with the CB unit (CB) meeting the requirements of pre-release testing parameters, the quality of the product ultimately confirmed by the outcomes observed posttransplant. CB is a biological produc作者: 急性 時間: 2025-3-28 17:28 作者: delta-waves 時間: 2025-3-28 21:29 作者: Deceit 時間: 2025-3-29 00:56
Cord Blood Graft Thawingred to other allogeneic hematopoietic progenitor cell (HPC) sources such as peripheral blood and bone marrow, are that CB HPCs allow higher HLA mismatch, result in lower G.HD rates, and are readily available for transplantation. Since CB units are small-dose, cryopreserved, and irreplaceable product作者: ineptitude 時間: 2025-3-29 05:21 作者: 縮短 時間: 2025-3-29 10:22 作者: FLIRT 時間: 2025-3-29 14:33
,The Metal—Nonmetal Bond in the Solid State,n to maternal donor screening, there are many in-process parameters of the CBU that must meet compliance in order for the CBU to be deemed to be of an acceptable quality for clinical use. This chapter outlines the criteria that together are used in the process of CB donor qualification.作者: Foreknowledge 時間: 2025-3-29 18:12
Amphibole group of silicates (Figures 1-25),ferent methods to collect, process, and cryopreserve CB units, increasing the complexity of their processing. In order to determine how to prepare CB units for infusion, transplant centers need to assess multiple factors including transplant program setting, patient demographics, and availability of trained laboratory staff.作者: frozen-shoulder 時間: 2025-3-29 20:06 作者: barium-study 時間: 2025-3-30 03:38
Cord Blood Graft Thawingferent methods to collect, process, and cryopreserve CB units, increasing the complexity of their processing. In order to determine how to prepare CB units for infusion, transplant centers need to assess multiple factors including transplant program setting, patient demographics, and availability of trained laboratory staff.作者: 執(zhí) 時間: 2025-3-30 06:17
C. Biran,M. Bordeau,M. P. Legerpt in a way that permits the cells to remain viable and functional in order for engraftment to occur. In this chapter, laboratory processes specifically pertaining to HPC, Apheresis and HPC, Marrow products will be discussed.作者: Herd-Immunity 時間: 2025-3-30 08:52
2569-1376 experts in the field.Draws attention to potentially high-impThis concise book examines clinically relevant issues relating to the ways in which bone marrow, cord blood and apheresis products, are processed and stored for the purpose of Hematopoietic Cell Transplantation and Cell Therapy. The twin ai
